| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 6 | |
| #2 | Singapore | 4 | |
| #3 | Canada | 3 | |
| #4 | China | 3 | |
| #5 | Republic of Korea | 3 | |
| #6 | Mexico | 3 | |
| #7 | WIPO (World Intellectual Property Organization) | 3 | |
| #8 | Australia | 2 | |
| #9 | EPO (European Patent Office) | 2 | |
| #10 | New Zealand | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mcchesney James D | 31 |
| #2 | Henri John T | 22 |
| #3 | Venkataraman Sylesh Kumar | 22 |
| #4 | Gundluru Mahesh Kumar | 22 |
| #5 | Nikoulin Igor | 9 |
| #6 | Rodenburg Douglas L | 9 |
| #7 | Bannister Steve J | 8 |
| #8 | Steve J Bannister | 1 |
| Publication | Filing date | Title |
|---|---|---|
| CA2922002A1 | Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation | |
| CN103763928A | Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents | |
| MX2013011694A | Taxane and abeo-taxane analogs. |